Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Mepha Pharm Group is a comprehensive pharmaceutical company based in Shijiazhuang, China, specializing in the research, development, manufacturing, and export of finished dosage forms and active pharmaceutical ingredients. The company maintains a diverse product portfolio that includes anti-infectives, antimalarials, cardiovascular agents, and nutritional supplements, all produced in GMP-certified facilities. Mepha Pharm is a significant player in the global generic drug market, with a strong focus on supplying affordable medicines to regions such as Africa, Southeast Asia, and Central Asia. Their manufacturing capabilities encompass a wide array of formulations, including tablets, capsules, powders for injection, and oral liquids. By integrating production with international trade, the group has established itself as a reliable partner for both government tenders and private healthcare distributors worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Mepha Pharm Group.